Grey A et al. |
Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate. |
2004 |
Calcif. Tissue Int. |
pmid:15354862
|
Kolahdooz Z et al. |
Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism. |
2015 |
Can J Neurol Sci |
pmid:25860537
|
Pal SK et al. |
A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. |
2017 |
Cancer |
pmid:27727447
|
Yang F et al. |
Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. |
2012 |
Cancer Biol. Ther. |
pmid:22406995
|
Beljanski V et al. |
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. |
2011 |
Cancer Biol. Ther. |
pmid:21258214
|
Milstien S and Spiegel S |
Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. |
2006 |
Cancer Cell |
pmid:16530698
|
Visentin B et al. |
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. |
2006 |
Cancer Cell |
pmid:16530706
|
Liang J et al. |
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. |
2013 |
Cancer Cell |
pmid:23273921
|
Alberg AJ et al. |
Plasma sphingolipids and lung cancer: a population-based, nested case-control study. |
2013 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:23749868
|
Sutphen R et al. |
Lysophospholipids are potential biomarkers of ovarian cancer. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15247129
|
Rolin J et al. |
FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. |
2010 |
Cancer Immunol. Immunother. |
pmid:19823820
|
Dai L et al. |
Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? |
2014 |
Cancer Invest. |
pmid:24499107
|
Vishwakarma S et al. |
Altered Expression of Sphingosine-1-Phosphate Metabolizing Enzymes in Oral Cancer Correlate With Clinicopathological Attributes. |
2017 |
Cancer Invest. |
pmid:28135860
|
Sun DF et al. |
Sphingosine 1-phosphate antagonizes the effect of all-trans retinoic acid (ATRA) in a human colon cancer cell line by modulation of RARβ expression. |
2012 |
Cancer Lett. |
pmid:22261335
|
Li MH et al. |
S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. |
2009 |
Cancer Lett. |
pmid:19131156
|
Li X et al. |
Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability. |
2009 |
Cancer Lett. |
pmid:19446953
|
Koh E et al. |
Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors. |
2007 |
Cancer Lett. |
pmid:17189669
|
Van Brocklyn J et al. |
Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. |
2002 |
Cancer Lett. |
pmid:12175535
|
Karahatay S et al. |
Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. |
2007 |
Cancer Lett. |
pmid:17619081
|
Van Brocklyn JR et al. |
Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. |
2003 |
Cancer Lett. |
pmid:12963123
|
Yester JW et al. |
Extracellular and intracellular sphingosine-1-phosphate in cancer. |
2011 |
Cancer Metastasis Rev. |
pmid:22002715
|
Li MH et al. |
Sphingolipid modulation of angiogenic factor expression in neuroblastoma. |
2011 |
Cancer Prev Res (Phila) |
pmid:21576349
|
Kleuser B et al. |
1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. |
1998 |
Cancer Res. |
pmid:9581819
|
Goetzl EJ et al. |
Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. |
1999 |
Cancer Res. |
pmid:10493533
|
Goetzl EJ et al. |
Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. |
1999 |
Cancer Res. |
pmid:10537322
|
Kilbey A et al. |
Runx regulation of sphingolipid metabolism and survival signaling. |
2010 |
Cancer Res. |
pmid:20587518
|
Pchejetski D et al. |
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. |
2005 |
Cancer Res. |
pmid:16357178
|
Shida D et al. |
Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. |
2008 |
Cancer Res. |
pmid:18701480
|
Bonnaud S et al. |
Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. |
2007 |
Cancer Res. |
pmid:17308123
|
Ader I et al. |
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. |
2009 |
Cancer Res. |
pmid:19383898
|
Wang F et al. |
Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors. |
1999 |
Cancer Res. |
pmid:10626811
|
Bonnaud S et al. |
Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. |
2010 |
Cancer Res. |
pmid:21118968
|
Clair T et al. |
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. |
2003 |
Cancer Res. |
pmid:14500380
|
Pyne S et al. |
Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. |
2011 |
Cancer Res. |
pmid:21940750
|
Nagahashi M et al. |
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. |
2012 |
Cancer Res. |
pmid:22298596
|
Taniguchi K et al. |
Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. |
2009 |
Cancer Sci. |
pmid:19493272
|
Wang F and Fishman DA |
Lysophosphatidic acid and invasion. |
2009 |
Cancer Treat. Res. |
pmid:19763441
|
Perry DK and Kolesnick RN |
Ceramide and sphingosine 1-phosphate in anti-cancer therapies. |
2003 |
Cancer Treat. Res. |
pmid:12613204
|
Xu Y et al. |
Lipid generation and signaling in ovarian cancer. |
2009 |
Cancer Treat. Res. |
pmid:19763440
|
Chumanevich AA et al. |
Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. |
2010 |
Carcinogenesis |
pmid:20688834
|
Tong X et al. |
The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus. |
2014 |
Cardiovasc Diabetol |
pmid:24751283
|
Tong X et al. |
High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. |
2013 |
Cardiovasc Diabetol |
pmid:23360427
|
Somers SJ et al. |
Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. |
2012 |
Cardiovasc Drugs Ther |
pmid:22392184
|
Deshpande GP et al. |
Effects of sphingosine-1-phosphate on acute contractile heart failure (ACHF). |
2010 |
Cardiovasc Drugs Ther |
pmid:20838867
|
Kelly-Laubscher RF et al. |
Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. |
|
Cardiovasc J Afr |
pmid:25000441
|
Meissner A et al. |
Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension. |
2017 |
Cardiovasc. Res. |
pmid:28082452
|
Ohmori T et al. |
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. |
2003 |
Cardiovasc. Res. |
pmid:12667959
|
Frias MA et al. |
Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. |
2009 |
Cardiovasc. Res. |
pmid:19151362
|
Takashima S et al. |
G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. |
2008 |
Cardiovasc. Res. |
pmid:18480127
|
Böhm A et al. |
Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. |
2013 |
Cardiovasc. Res. |
pmid:23658376
|